Search Results - "Carrascosa Carrillo, Jose Manuel"

Refine Results
  1. 1

    From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment by Vidal, Silvia, Puig, Lluís, Carrascosa-Carrillo, José-Manuel, González-Cantero, Álvaro, Ruiz-Carrascosa, José-Carlos, Velasco-Pastor, Antonio-Manuel

    “…The paradigm of psoriasis as a Th17-driven disease has evolved in the last years towards a much deeper knowledge of the complex pathways, mechanisms, cells,…”
    Get full text
    Journal Article
  2. 2

    Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document by Belinchón Romero, Isabel, Dauden, Esteban, Ferrándiz Foraster, Carlos, González-Cantero, Álvaro, Carrascosa Carrillo, Jose Manuel

    Published in Annals of medicine (Helsinki) (01-01-2021)
    “…To critically analyse and define therapeutic objectives, response to treatment evaluation and related decisions in psoriasis. Expert consensus meetings, a…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines by Belinchón Romero, Isabel, Dauden, Esteban, Ferrándiz Foraster, Carlos, González-Cantero, Álvaro, Carrascosa Carrillo, Jose Manuel

    Published in The Journal of dermatological treatment (03-04-2022)
    “…Response to treatments in psoriasis can be assessed using the PASI response 50, 75, 90 or 100. Achieving a PASI 100 response would mean a complete resolution…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts by García‐Doval, I., Hernández, M.V., Vanaclocha, F., Sellas, A., Cueva, P., Montero, D., Rodríguez, Basilio, Barceló, Mireia, Farietta, Sandra, Montoro, María, González, Ainhoa, Herráez, Elena, Ruíz‐Montesino, Mª Dolores, Vargas, Carmen, Pérez‐Pampín, Eva, Ortiz, Ana Mª, Tomero, Eva, Sifuentes, Alberto, Antón, Fred, Zea, Antonio, Manero Ruiz, Francisco Javier, Beltrán, Chesús, Giménez Úbeda, Eugenio, Jimenez Zorzo, Fernando, Marzo, Jesús, Medrano, Marta, Pecondón, Ángela, Sanmartí, Raimon, Cañete, Juan D., Rodriguez Lozano, Carlos, Naranjo, Antonio, Ojeda, Soledad, Hernández, Félix Francisco, Erausquin, Celia, Rúa, Íñigo, Quevedo, Juan Carlos, Manrique, Sara, Ureña, Inmaculada, Irigoyen, María Victoria, Cano, Laura, Pardo, Rosa Roselló, Mateo, Isabel, Garcia, Javier, Enríquez, Eugenia, Campos, Cristina, García Borras, Juan José, Nogueroles, Rosa, Muñoz, Luisa, Luis Valero, José, Ibáñez, Andrés, Carretero Hernández, Gregorio, Torrado, Rosa, Carrascosa Carrillo, José Manuel, Ferrándiz, Carlos, Rivera, Raquel, Dauden, Esteban, Llamas, Mar, Mejías, Sagrario Galiano, Gómez García, Francisco José, Jiménez Puya, Rafael, Herrera, Enrique, Mendiola, Mª Victoria, Belinchón Romero, Isabel, Sánchez Carazo, José Luis, López Estebaranz, José Luis, Ruiz Genao, Diana, Alsina, Mercè, Ferran, Marta

    Published in British journal of dermatology (1951) (01-03-2017)
    “…Summary Background Information on the safety of tumour necrosis factor (TNF) antagonists frequently arises from their use in rheumatic diseases, their first…”
    Get full text
    Journal Article